Airway Protection Rehabilitation for Parkinson's Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
Airway protective disorders are a prevalent and progressive consequence of Parkinson's Disease (PD), and often result in aspiration pneumonia which is the leading cause of death in PD. Despite this, a large number of patients with PD do not access specialized services to address these critical deficits. The investigators will examine the comparative effectiveness of a novel treatment paradigm delivered in-person versus via telehealth in persons with PD, as well as the role of patient burden and treatment adherence on outcomes; thus, the proposed research is relevant to public health and in line with NIH's mission to identify novel, efficacious, and accessible rehabilitation strategies for short- and long-term improvement of dysfunctional airway protection in PD.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is Expiratory Muscle Strength Training (EMST) safe for humans?
How does the treatment Expiratory Muscle Strength Training + Cough Skill Training differ from other treatments for Parkinson's Disease?
This treatment is unique because it combines exercises to strengthen breathing muscles and improve cough skills, which can help with swallowing and airway protection in Parkinson's Disease. Unlike many treatments that focus on medication, this approach uses physical training to enhance respiratory function and can be delivered via telehealth, making it more accessible.56789
What data supports the effectiveness of the treatment Expiratory Muscle Strength Training + Cough Skill Training for Parkinson's Disease?
Who Is on the Research Team?
Michelle Troche, PhD
Principal Investigator
Teachers College, Columbia University
Are You a Good Fit for This Trial?
This trial is for people aged 50-90 with Parkinson's Disease who have trouble swallowing or coughing but aren't currently getting therapy for it. They must be diagnosed by a specialist and can't have other neurological disorders, recent smoking history, breathing diseases, severe depression or dementia.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intensive Treatment
Participants undergo four weeks of intensive Expiratory Muscle Strength Training (EMST) and Cough Skill Training (CST) delivered in-person or via telehealth
Maintenance Treatment
Participants continue with a long-term EMST+CST maintenance program offered in-person or via telehealth
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Expiratory Muscle Strength Training + Cough Skill Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Teachers College, Columbia University
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Purdue University
Collaborator